Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down 0.10% Nasdaq Up 0.23%
Streaming
Ticker Tape: On

CytRx Corporation (CYTR)

-NasdaqCM
3.23 0.23(7.67%) Apr 17, 4:00PM EDT
Get the big picture on all your investments.
Prev Close:3.00
Open:3.01
Bid:3.27 x 20000
Ask:3.48 x 6000
1y Target Est:11.00
Beta:1.25
Next Earnings Date:N/A
Day's Range:2.95 - 3.26
52wk Range:1.95 - 8.35
Volume:1,144,414
Avg Vol (3m):2,702,220
Market Cap:179.47M
P/E (ttm):N/A
EPS (ttm):-1.44
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CYTR

Reports

Comparison

Symbol% ChgMkt Cap
CYTRUp 7.67%179.47M
LLY64.47B
NVS205.42B
SNY138.26B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):555.64
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.60
Quarterly EPS Est (Mar-14) :-0.18
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

CytRx Corporation operates as a biopharmaceutical research and development company specializing in oncology. The company’s product candidate includes aldoxorubicin that has completed Phase IIb clinical trial as a first-line therapy for soft t... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback